Phacilitate Leaders World

Conference speakers

Loading
Oliver Bartelsen

Dr Oliver Bartelsen

Global Head of Business Development and Industrial Services, Miltenyi Biotec

As the Head of Business Development at Miltenyi Biotec, Oliver is responsible for the Company’s strategic collaborations with Biotech and Pharma in Cell and Gene Therapy (CGT). Joining Miltenyi Biotec in 2009, he has been instrumental to build the Company’s industry business becoming a global solution provider in the CGT field addressing challenges in development, manufacturing and testing of CGT products. Based on Miltenyi Biotec’s foundations of its tool and reagent catalogue business, Oliver and his team are doing deals with the CGT industry from strategic supply to R&D collaborations in technology platform and CGT product development and contract manufacturing.  Before joining Miltenyi Biotec, Oliver worked in the vaccine industry in positions with increasing responsibilities in R&D, project management, industrialization and business development at Rhein Biotech, GreenCross Vaccine, Berna Biotech, Crucell and Dynavax. Oliver holds a doctoral degree in Biochemistry from the University of Bonn, Germany.

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK